February 21, 2012 -- Shanghai Fosun Pharma, a prolific dealmaker, has bought an 18% stake in SD Biosensor Inc., a Korean company that makes in-vitro diagnostic devices. Fosun will become SDB’s China distributor as part of the deal. Fosun said SDB’s products would add rapid diagnostic tests to its existing portfolio of diagnostic kits. SDB’s major revenue-generators are tests for blood sugar and blood lipids. More details....
Stock Symbol: (SHA: 600196)
